Condition
Acute Exacerbation
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Unknown2
Recruiting1
Completed1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07714863Recruiting
ML-Based ABPA Recurrence Prediction and Clinical Utility
NCT07627594Not Yet Recruiting
Safety of Bronchoscopy in Patients With Interstitial Lung Disease
NCT03979430Not ApplicableCompletedPrimary
Early Detection of Acute Exacerbation in Patients With Idiopathic Lung Fibrosis - a Pilot Study
NCT03428412Phase 3Unknown
Effects of Traditional Chinese Medicine on AECOPD Patients
NCT00271128Unknown
NT-proBNP for Evaluation of the Dyspneic Patient in the Emergency Room and the Medical Ward
Showing all 5 trials